MLTX - MoonLake Immunotherapeutics

QQQ $ 602.20 $ 4.22 (0.71 %)

DIA $ 462.77 $ 0.00 (0 %)

SPY $ 665.10 $ 2.94 (0.44 %)

TLT $ 90.72 $ -0.20 (-0.22 %)

GLD $ 387.60 $ 6.60 (1.73 %)

Previous Close

$ 9.89

Open

$ 10.09

Bid

$ 9.80 x 451

Ask

$ 9.89 x 7

Day's Range

$ 9.48 - $ 10.25

52 Week Range

$ 5.95 - $ 62.75

Volume

5,920,030

Average Volume

Market Cap

635.24M

Beta (5Y Monthly)

$ 0.59

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	02-26-2025	12-31-2024	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-07-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-14-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-20-2023	12-31-2022	10-K
12	11-14-2022	09-30-2022	10-Q
13	08-12-2022	06-30-2022	10-Q
14	05-16-2022	03-31-2022	10-Q
15	02-17-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-16-2021	06-30-2021	10-Q
18	05-21-2021	03-31-2021	10-Q
19	03-31-2021	12-31-2020	10-K
20	12-03-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Top 3 Health Care Stocks That Are Preparin...
10/06/2025 10:23:07

HC Wainwright & Co. Downgrades MoonLake to...
10/02/2025 10:43:44

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades MoonLake (NASDAQ:MLTX) from Buy to Neutral.

Guggenheim Maintains Buy on MoonLake, Lowe...
09/30/2025 14:24:34

Guggenheim analyst Yatin Suneja maintains MoonLake (NASDAQ:MLTX) with a Buy and lowers the price target from $80 to $20.

Wedbush Maintains Outperform on MoonLake, ...
09/30/2025 12:51:29

Wedbush analyst Yun Zhong maintains MoonLake (NASDAQ:MLTX) with a Outperform and lowers the price target from $80 to $18.

Citigroup Downgrades MoonLake to Neutral, ...
09/30/2025 11:48:39

Citigroup analyst Samantha Semenkow downgrades MoonLake (NASDAQ:MLTX) from Buy to Neutral and lowers the price target from $...

Needham Maintains Buy on MoonLake, Lowers ...
09/30/2025 10:22:01

Needham analyst Serge Belanger maintains MoonLake (NASDAQ:MLTX) with a Buy and lowers the price target from $66 to $20.

wolfspeed-tilray-robinhood-etsy-and-moonlake-immunotherapeutics-why-these-5-stocks-are-on-investors-radars-today-corrected

Wolfspeed, Tilray, Robinhood, Etsy, And Mo...
09/30/2025 01:49:40

U.S. stocks advanced today, with the Nasdaq climbing about 107 points, or 0.48%, to 22,591.15. The S&P 500 added 0.26% to c...

crude-oil-falls-sharply-carnival-posts-upbeat-earnings

Crude Oil Falls Sharply; Carnival Posts Up...
09/29/2025 17:14:55

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Monday. The Dow traded do...

12 Health Care Stocks Moving In Monday's I...
09/29/2025 17:06:50

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

nasdaq-jumps-150-points-us-pending-home-sales-rise

Nasdaq Jumps 150 Points; US Pending Home S...
09/29/2025 14:11:58

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market ...

RBC Capital Downgrades MoonLake to Sector ...
09/29/2025 13:43:04

RBC Capital analyst Brian Abrahams downgrades MoonLake (NASDAQ: MLTX) from Outperform to Sector Perform and lowers the price...

12 Health Care Stocks Moving In Monday's P...
09/29/2025 12:09:33

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

inventiva-moonlake-immunotherapeutics-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

Inventiva, MoonLake Immunotherapeutics And...
09/29/2025 12:06:27

U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiv...

this-electronic-arts-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-monday

This Electronic Arts Analyst Is No Longer ...
09/29/2025 11:52:38

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

MoonLake Immunotherapeutics Reported Sunda...
09/29/2025 10:48:41

BTIG Downgrades MoonLake to Neutral, Maint...
09/29/2025 10:25:36

BTIG analyst Julian Harrison downgrades MoonLake (NASDAQ: MLTX) from Buy to Neutral and maintains the price target from $85 ...

why-merus-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket

Why Merus Shares Are Trading Higher By 38%...
09/29/2025 09:07:53

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus fo...

Reported Sunday, MoonLake Phase 3 VELA Tri...
09/29/2025 06:35:25

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with modera...

Goldman Sachs Maintains Buy on MoonLake, R...
08/06/2025 14:41:58

Goldman Sachs analyst Richard Law maintains MoonLake (NASDAQ:MLTX) with a Buy and raises the price target from $74 to $82.

MoonLake Q2 2025 EPS $(0.87) Misses $(0.72...
08/05/2025 11:30:10

Ended the second quarter with $425.1 million in cash, cash equivalents and short-term marketable debt securities with up to an ...